Waxman Vows To Fight Bill That Would Extend Drug Patents, Data Exclusivity

Law360, New York (March 6, 2005, 12:00 AM EST) -- One of the authors of the Hatch-Waxman Act has vowed to oppose a bill that would extend data exclusivity and patents for “a very large number of medicines” if drug companies develop biodefense countermeasures.

In a speech to the annual conference for the Generic Pharmaceutical Association, Representative Henry Waxman said the bill, co-sponsored by Senators Joseph Lieberman and Orrin Hatch, was a “misguided giveaway to the brand drug industry.”

Waxman said the bill would undermine the balance between incentives for innovator companies and market access for...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.